Serum insulin-like growth factor-1, asthma, and lung function among British adults.
Serum insulin-like growth factor-1, asthma, and lung function among British adults.
复制标题
DOI:
10.1016/j.anai.2020.12.005
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Celedón JC
中科院分区:
文献类型:
--
作者:
Han YY;Yan Q;Chen W;Forno E;Celedón JC
Insulin-like growth factor-1 (IGF-1) plays a key role in the pathogenesis of metabolic syndrome (MS), which is in turn associated with asthma. Whether IGF-1 contributes to asthma causation or asthma severity is largely unknown. To examine the relation between serum IGF-1 and asthma, asthma outcomes, and lung function in adults. Cross-sectional study of 297,590 adults (aged 40–69 years) who participated in the United Kingdom Biobank, had no diagnosis of diabetes, and were not on insulin. Multivariable logistic or linear regression was used to analyze serum IGF-1 and physician-diagnosed asthma, current wheeze, asthma hospitalizations, and lung function measures (FEV 1, FVC and FEV 1 /FVC). Serum IGF-1 levels above the lowest quartile (Q1) were significantly associated with lower odds of asthma (adjusted odds ratio [aOR] for fourth quartile (Q4) vs. Q1=0.88, 95% confidence interval [CI]=0.85–0.91). Among participants with asthma, IGF-1 levels above Q1 were significantly associated with lower odds of current wheeze (aOR for Q4 vs. Q1=0.89, 95% CI=0.83–0.96), but not with asthma hospitalizations. Serum IGF-1 was significantly and positively associated with FEV 1 (b=20.9 mL, 95%CI=19.1–22.7) and FVC (b=25.6 mL, 95%CI=23.4–27.7), regardless of an asthma diagnosis; these associations were significant in men and women, with larger estimated effects in men. In a large study of British adults, higher serum IGF-1 levels were associated with lower odds of asthma and current wheeze, and higher FEV 1 and FVC. Our findings suggest potential beneficial effects of circulating IGF-1 on asthma and asthma outcomes in adults.
登录
查看更多内容
影响因子:
5
作者:
Fry A;Littlejohns TJ;Sudlow C;Doherty N;Adamska L;Sprosen T;Collins R;Allen NE
通讯作者:
Allen NE
影响因子:
5.4
作者:
Simpson A;Petnga W;Macaulay VM;Weyer-Czernilofsky U;Bogenrieder T
通讯作者:
Bogenrieder T
影响因子:
4.6
作者:
Park S;Choi NK;Kim S;Lee CH
通讯作者:
Lee CH
DOI:
10.1183/20734735.000318
发表时间:
2018-06
期刊:
Breathe (Sheffield, England)
影响因子:
--
作者:
LoMauro A;Aliverti A
通讯作者:
Aliverti A
影响因子:
3.1
作者:
Gifford AH;Nymon AB;Ashare A
通讯作者:
Ashare A